Credit Suisse’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-61,820
| Closed | -$1.81M | – | 4355 |
|
|
2017
Q3 | $1.81M | Buy |
61,820
+36,964
| +149% | +$1.04M | ﹤0.01% | 2623 |
|
|
2017
Q2 | $653K | Sell |
24,856
-11,376
| -31% | -$280K | ﹤0.01% | 2964 |
|
|
2017
Q1 | $848K | Sell |
36,232
-8,307
| -19% | -$205K | ﹤0.01% | 2986 |
|
|
2016
Q4 | $1.12M | Buy |
44,539
+8,923
| +25% | +$225K | ﹤0.01% | 2941 |
|
|
2016
Q3 | $1M | Sell |
35,616
-21,603
| -38% | -$554K | ﹤0.01% | 2955 |
|
|
2016
Q2 | $1.41M | Buy |
57,219
+27,301
| +91% | +$677K | ﹤0.01% | 2627 |
|
|
2016
Q1 | $661K | Sell |
29,918
-9,842
| -25% | -$262K | ﹤0.01% | 3035 |
|
|
2015
Q4 | $1.39M | Buy |
39,760
+5
| +0% | +$157 | ﹤0.01% | 2552 |
|
|
2015
Q3 | $1.13M | Sell |
39,755
-6,067
| -13% | -$204K | ﹤0.01% | 2714 |
|
|
2015
Q2 | $1.52M | Buy |
45,822
+3,679
| +9% | +$113K | ﹤0.01% | 2788 |
|
|
2015
Q1 | $1.19M | Sell |
42,143
-45,502
| -52% | -$1.13M | ﹤0.01% | 2829 |
|
|
2014
Q4 | $1.81M | Sell |
87,645
-1,705
| -2% | -$40.5K | ﹤0.01% | 2620 |
|
|
2014
Q3 | $2.18M | Buy |
89,350
+41,215
| +86% | +$1.09M | ﹤0.01% | 2421 |
|
|
2014
Q2 | $1.38M | Buy |
48,135
+5,879
| +14% | +$164K | ﹤0.01% | 3024 |
|
|
2014
Q1 | $1.18M | Sell |
42,256
-57,518
| -58% | -$1.41M | ﹤0.01% | 2977 |
|
|
2013
Q4 | $2.15M | Buy |
+99,774
| New | +$1.81M | ﹤0.01% | 2589 |
|
Credit Suisse's PMC Position: Q4 2017 in Review
Credit Suisse sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 61,820 shares — an estimated $1.81M sold.
Credit Suisse first reported a position in PMC in Q4 2013 and held it in 16 quarters. The position peaked at $2.18M in Q3 2014. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Credit Suisse reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Credit Suisse sold 61,820 PharMerica Corporation shares in Q4 2017, an estimated $1.81M.
- Credit Suisse first reported a position in PharMerica Corporation in Q4 2013 and held it in 16 quarters.
- Credit Suisse's PharMerica Corporation position peaked at $2.18M in Q3 2014.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Credit Suisse's 13F filing for Q4 2017, filed 14 Feb 2018.